• Home
  • PR

PR

News

게시물 상세
OliX Receives Notice of Allowance from US Patent and Trademark Office for Improved Technology
Date : 2021-05-26     View : 800

OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Improved Intracellular Delivery Platform Technology for RNAi Therapeutics

 

Learn more: https://www.biospace.com/article/releases/olix-pharmaceuticals-receives-notice-of-allowance-from-u-s-patent-and-trademark-office-for-improved-intracellular-delivery-platform-technology-for-rnai-therapeutics/

 

Source _ OliX Pharmaceuticals

Prev OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA
Next OliX and PCI Biotech Announce a Collaboration to Combine Technologies